Britain’s life sciences industry is on the cusp of revolution if it can rebuild faith in data Nicole Mather Across life sciences, the need to develop treatments and vaccines for Covid-19 has been driving collaboration – bringing private, public and third sectors together. In Rishi Sunak’s spending review last year, he pledged to grow the UK public sector investment in research and development from £14.8bn to £22bn. To compete internationally, by 2024 the UK [...]
